Education
About Us
Working with TipRanks
Follow Us
Jack Kaye Insider Profile
4 Followers
Jack Kaye, Director at Keryx Biopharma, holds 20.44K shares in uniQure (Ticker: QURE), holds 59.65K shares in Dyadic International (Ticker: DYAI), holds 85.00K shares in Keryx Biopharma (Ticker: KERX). Most recently, Jack Kaye Sold ― shares of uniQure on Jun 24, 2025 for an estimated value of 30.52K.
Profitable Transactions
5 out of 9 Profitable Transactions
Average Return
-15.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Jack Kaye
Jack Kaye's Trading History
Keryx Biopharma
Jun 18, 2015
―
Uninformative Buy
―
$285.60K
uniQure
Jun 24, 2025
Director
Informative Sell
30.52K
$274.90K
Dyadic International
Mar 07, 2025
Director
Uninformative Buy
3.30K
$56.61K
List of latest transactions for each holding click on a transaction to see Jack Kaye's performance on stock
You May Also Like
Jack Kaye insider profile FAQ
What is the percentage of profitable transactions made by Jack Kaye?
The percentage of profitable transactions made by Jack Kaye is 56%.
What is the average return per transaction made by Jack Kaye?
The average return per transaction made by Jack Kaye is -15.60%.
What stocks does Jack Kaye hold?
Jack Kaye holds: KERX, QURE, DYAI stocks.
What was Jack Kaye’s latest transaction?
Jack Kaye latest transaction was an Informative Sell of $30.52K.
What was Jack Kaye's most profitable transaction?
Jack Kaye’s most profitable transaction was an Informative Sell of QURE stock on June 20, 2023. The return on the trade was 76.50%.
What is Jack Kaye's role in Keryx Biopharma?
Jack Kaye's role in Keryx Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.